TuesdaySep 27, 2022 1:52 pm

TinyGemsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Collaborates with EVERSANA(R) to Bring BEATdiabetes Solution to Market

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced its entry into a preliminary agreement with EVERSANA(R), a pioneer of next-gen commercial services to the global life sciences industry. The agreement covers the U.S. and all global sales and marketing of Nemaura’s diabetes management program, BEATdiabetes, which is based on Nemaura’s noninvasive glucose monitoring solution, proBEAT(TM). Nemaura and EVERSANA will collaborate to develop the optimal launch strategy for large-scale adoption of the program, including franchising and direct sales to self-insured corporate clients and health…

Continue Reading

TuesdaySep 27, 2022 10:46 am

TinyGemsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC), New Investor Group Sign $3.67M Equity Investment Agreements

AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, has entered into legally binding investment agreements with nine institutional and individual investors; the agreements outline an investment in the company of approximately $3.67 million. According to the announcement, the various shares purchase agreements outline plans for a private offering of $3.67 million earmarked to purchase 36.7 million of the company’s Class A shares; the company anticipates that the investment will be complete this month. “This equity investment is important to the company’s operations as well as research and…

Continue Reading

TuesdaySep 27, 2022 10:32 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Releases New Info about Upcoming Mullen Five RS

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting new information about its upcoming, range-topping new model: the Five RS. Mullen announced the new vehicle late last year, calling it an “ultra-high performance EV” and reporting that it will feature an 800-volt architecture, all-wheel drive and a claimed output in excess of 1,000 hp (746 kW/1,014 PS). Noting that there are “risks and uncertainties” about its claims, the company anticipates that the crossover should be able to accelerate from 0 to 60 mph in under two seconds, reaching top speeds of approximately 200 mph. The new information…

Continue Reading

MondaySep 26, 2022 3:39 pm

TinyGemsBreaks – Cepton Inc.’s (NASDAQ: CPTN) Short-Range Lidar Solution Aims to Bring Safety Benefits to Everyone on the Road

Cepton (NASDAQ: CPTN), a Silicon Valley innovator of lidar-based solutions for autonomous vehicles (“AV”), advanced driver assistance systems (“ADAS”) and smart technology spaces, is leading the way with Nova, an award-winning short-range lidar solution that’s lightweight, flexible, energy-efficient, and easy to integrate into passenger and commercial vehicles. “CPTN recently announced the company’s collaboration with ZKW Group GmbH to demonstrate Nova at the IAA Transportation Conference… Cepton’s exhibit demonstrated how Nova helps eliminate blind spots and create a ‘safety cocoon’ around the vehicle by combining high-resolution, superior field of view coverage in all directions. Nova’s super-compact form additionally features flexible options…

Continue Reading

MondaySep 26, 2022 1:11 pm

TinyGemsBreaks – GreenBox POS (NASDAQ: GBOX) Shareholders Voting on New Brand: RYVYL

GreenBox (NASDAQ: GBOX), a rapidly growing financial technology company leveraging unique blockchain security and token technology to deliver customized blockchain-driven solutions, is rebranding the company as RYVYL; the company is asking shareholders to confirm the move ahead of the company’s annual meeting, which is scheduled for Oct. 6, 2022; shareholder vote results will be reported after the meeting. According to the announcement, the new name and overhauled look is more accurately communicating the company’s exclusive end-to-end suite of payment and financial service products for both businesses and consumers as well as bringing world-class branding to the fintech space. GreenBox POS…

Continue Reading

MondaySep 26, 2022 11:34 am

TinyGemsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Issues Letter to Stockholders

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, today released a letter to stockholders from its Chief Executive Officer Dr. James Woody. In the letter, Dr. Woody discussed the company’s continued status to remain on track with clinical development plans. “Currently, we have an active clinical development program that includes phase 2a and phase 2b proof-of-concept data, which we believe demonstrates that anti-TNF therapy can prevent the progression of Dupuytren’s disease in its early stages, as well as plans for two additional phase 2 studies, one in frozen shoulder, which has recently commenced, and the other in post-operative cognitive…

Continue Reading

MondaySep 26, 2022 11:23 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Dates for Strikingly Different Fall Tour

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released the kickoff dates for its Strikingly Different tour; the fall tour features the Mullen FIVE EV Crossover. The tour begins on Oct. 27–28, 2022, at the Rose Bowl in Pasadena followed by a stop at the Las Vegas Motor Speedway on Nov. 10–11. In addition, the tour will make stops in both Dallas and Houston in November, with December locations slated in Memphis, Miami, Atlanta and Charlotte. The second leg of the tour will begin in spring 2023 with the tour heading to the East Coast as well…

Continue Reading

MondaySep 26, 2022 10:35 am

TinyGemsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Unveils In-House Product Design Studio

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, announced that it now has in-house design capabilities. Called Ideanomics Design, the new approach will strengthen the company’s position as a leading commercial EV and allow the company to have a powerful impact on the future of commercial EV solutions by creating high-performance electric mobility and charging solutions. According to the announcement, the new service will also embed a more cost-effective, efficient and standardized design process across the company. Ideanomics operates three verticals: Mobility, Energy and Capital. Each one is charged with being accountable for managing…

Continue Reading

MondaySep 26, 2022 10:21 am

TinyGemsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Expands Global Footprint to Add 3 International Markets

Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. The company today announced that it has completed its first exports of Colombian grown high-CBD dried cannabis flower to Switzerland and the Czech Republic as well as CBD isolate to the United States. “As our global distribution network continues to evolve, adding these three industry-leading countries to our footprint is a major milestone for Flora,” said Luis Merchan, chairman and CEO of Flora Growth. “Our cultivation operation in Colombia, which provides high-quality, high-margin flower and derivatives, has experienced increasing demand. These exports are…

Continue Reading

FridaySep 23, 2022 2:40 pm

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces 2022 Financial Results, Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the fiscal year ended June 30, 2022. “In the final quarter of our fiscal 2022, as well as throughout the previous fiscal year, we have made important advancements in our pharmaceutical drug development programs, including expanding our phase 2 clinical trial for the treatment of symptoms related to epidermolysis bullosa to include adolescents, and initiating a research collaboration agreement to further screen cannabinoid analogs for potential therapeutic uses. As announced on Sept. 8, 2022, we have…

Continue Reading

Contact us: (512) 354-7000